Highbridge Capital Management’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-475,478
Closed -$4.86M 532
2022
Q4
$4.86M Sell
475,478
-411,225
-46% -$4.15M 0.13% 183
2022
Q3
$8.86M Buy
886,703
+282,322
+47% +$2.8M 0.12% 210
2022
Q2
$6.03M Buy
604,381
+76,893
+15% +$759K 0.14% 252
2022
Q1
$5.17M Sell
527,488
-129,627
-20% -$1.27M 0.12% 234
2021
Q4
$6.44M Buy
+657,115
New +$6.41M 0.14% 213

Other funds holding PEPL

Highbridge Capital Management's PEPL Position: Q1 2023 in Review

Highbridge Capital Management sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 475,478 shares — an estimated $4.86M sold.

Highbridge Capital Management first reported a position in PEPL in Q4 2021 and held it in 5 quarters. The position peaked at $8.86M in Q3 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • Highbridge Capital Management reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Highbridge Capital Management sold 475,478 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $4.86M.
  • Highbridge Capital Management first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
  • Highbridge Capital Management's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $8.86M in Q3 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on Highbridge Capital Management's 13F filing for Q1 2023, filed 11 May 2023.